There are 2949 resources available
FGFR inhibitors
Presenter: Yohann Loriot
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Antibody Drug Conjugate (ADC)
Presenter: Victor Moreno Garcia
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Epigenetic drugs: EZH2, BET and LDSD1
Presenter: Sophie Postel-Vinay
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Future strategies of using radiotherapy as an immune-stimulating agent
Presenter: Fernanda Herrera
Session: New drugs in development: What will be approved in 2025?
Resources:
Slides
Webcast
Leveraging mutational signatures for mutational calling in cell-free tumour DNA
Presenter: Dan Landau
Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
Resources:
Slides
Webcast
Who should get an I-O combination?
Presenter: Marina Garassino
Session: Maximising the benefit of immuno-oncology
Resources:
Slides
Webcast
Biomarkers
Presenter: Naiyer Rizvi
Session: Maximising the benefit of immuno-oncology
Resources:
Slides
Webcast
What to do post-IO failure
Presenter: Pilar Garrido Lopez
Session: Maximising the benefit of immuno-oncology
Resources:
Slides
Webcast
Emerging targets in immunotherapy
Presenter: Solange Peters
Session: Maximising the benefit of immuno-oncology
Resources:
Slides
Webcast
Q&A and live discussion
Presenter: Dan Landau
Session: Liquid biopsy: Beyond targeted panel sequencing in cancer research and therapy
Resources:
Webcast